Cell transplantation preserves cardiac function after infarction by infarct stabilization: Augmentation by stem cell factor

被引:71
作者
Fazel, S [1 ]
Chen, LW [1 ]
Weisel, RD [1 ]
Angoulvant, D [1 ]
Seneviratne, C [1 ]
Fazel, A [1 ]
Cheung, P [1 ]
Lam, J [1 ]
Fedak, PWM [1 ]
Yau, TM [1 ]
Li, RK [1 ]
机构
[1] Univ Toronto, Toronto Gen Hosp, Div Cardiac Surg, Toronto, ON M5G 2C4, Canada
基金
加拿大健康研究院;
关键词
D O I
10.1016/j.jtcvs.2005.07.012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: We hypothesized that implantation of adult mesenchymal stem cells after acute myocardial infarction mobilizes bone marrow precursor cells by activating the stem cell factor pathway, and that overdriving this pathway would enhance the beneficial effects of cell transplantation. Methods: After coronary ligation, medium, mesenchymal stem cells, or stem cell factor-overproducing mesenchymal stem cells were injected into the anterior left ventricle. Cells from beta-galactosidase transgenic mice enabled tracking of injected cells. The global and local impact of the cells was evaluated by measuring cytokine levels, endothelial progenitor cells, and myocardial angiogenesis, and by addressing cardiomyogenesis with confocal microscopy. The impact on cardiac function was evaluated by pressure-volume loops. Ventricular morphometrics were measured after in situ perfusion-fixation of the hearts at physiologic pressures. Results: Implantation of mesenchymal stem cells increased myocardial stem cell factor levels 2.0-fold, endothelial progenitor cell mobilization 2.7-fold, and myocardial angiogenesis 2.3-fold (P <.05), but did not induce mitogenesis in host cardiomyocytes or give rise to beta-galactosidase-expressing cardiomyocytes. Cell-transplanted groups had improved indices of cardiac function, including preload recruitable stroke work and end-systolic elastance (P <.001). Cell transplantation resulted in 2.0-fold smaller ventricular volumes (P =.001) and 2.0-fold reduced infarct scar area (P =.056), but had no effect on the volume of spared myocardium. Stem cell factor overproduction imparted greater functional benefit without inducing detectable histologic cardiomyocyte regeneration. Conclusion: Mesenchymal stem cell implantation after myocardial infarction facilitates functional cardiac regeneration without myocyte regeneration through augmentation of endogenous infarct repair, which is enhanced by stem cell factor.
引用
收藏
页码:1310 / 1318
页数:9
相关论文
共 28 条
[11]  
Kunisada T, 1998, DEVELOPMENT, V125, P2915
[12]   Mobilization of bone marrow-derived stem cells after myocardial infarction and left ventricular function [J].
Leone, AM ;
Rutella, S ;
Bonanno, G ;
Abbate, A ;
Rebuzzi, AG ;
Giovannini, S ;
Lombardi, M ;
Galiuto, L ;
Liuzzo, G ;
Andreotti, F ;
Lanza, GA ;
Contemi, AM ;
Leone, G ;
Crea, F .
EUROPEAN HEART JOURNAL, 2005, 26 (12) :1196-1204
[13]   CD117+ stem cells play a key role in therapeutic angiogenesis induced by bone marrow cell implantation [J].
Li, TS ;
Hamano, K ;
Nishida, M ;
Hayashi, M ;
Ito, H ;
Mikamo, A ;
Matsuzaki, M .
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY, 2003, 285 (03) :H931-H937
[14]   Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages [J].
Majumdar, MK ;
Thiede, MA ;
Haynesworth, SE ;
Bruder, SP ;
Gerson, SL .
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH, 2000, 9 (06) :841-848
[15]   Mesenchymal stem cells modified with Akt prevent remodeling and restore performance of infarcted hearts [J].
Mangi, AA ;
Noiseux, N ;
Kong, DL ;
He, HM ;
Rezvani, M ;
Ingwall, JS ;
Dzau, VJ .
NATURE MEDICINE, 2003, 9 (09) :1195-1201
[16]   Increased circulating hematopoietic and endothelial progenitor cells in the early phase of acute myocardial infarction [J].
Massa, M ;
Rosti, V ;
Ferrario, M ;
Campanelli, R ;
Ramajoli, I ;
Rosso, R ;
De Ferrari, GM ;
Ferlini, M ;
Goffredo, L ;
Bertoletti, A ;
Klersy, C ;
Pecci, A ;
Moratti, R ;
Tavazzi, L .
BLOOD, 2005, 105 (01) :199-206
[17]   Cardiomyocytes fuse with surrounding noncardiomyocytes and reenter the cell cycle [J].
Matsuura, K ;
Wada, H ;
Nagai, T ;
Iijima, Y ;
Minamino, T ;
Sano, M ;
Akazawa, H ;
Molkentin, JD ;
Kasanuki, H ;
Komuro, I .
JOURNAL OF CELL BIOLOGY, 2004, 167 (02) :351-363
[18]   Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts [J].
Murry, CE ;
Soonpaa, MH ;
Reinecke, H ;
Nakajima, H ;
Nakajima, HO ;
Rubart, M ;
Pasumarthi, KBS ;
Virag, JI ;
Bartelmez, SH ;
Poppa, V ;
Bradford, G ;
Dowell, JD ;
Williams, DA ;
Field, LJ .
NATURE, 2004, 428 (6983) :664-668
[19]   Mobilized bone marrow cells repair the infarcted heart, improving function and survival [J].
Orlic, D ;
Kajstura, J ;
Chimenti, S ;
Limana, F ;
Jakoniuk, I ;
Quaini, F ;
Nadal-Ginard, B ;
Bodine, DM ;
Leri, A ;
Anversa, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2001, 98 (18) :10344-10349
[20]   Bone marrow cells regenerate infarcted myocardium [J].
Orlic, D ;
Kajstura, J ;
Chimenti, S ;
Jakoniuk, I ;
Anderson, SM ;
Li, BS ;
Pickel, J ;
McKay, R ;
Nadal-Ginard, B ;
Bodine, DM ;
Leri, A ;
Anversa, P .
NATURE, 2001, 410 (6829) :701-705